Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > bid and ask (manipulation? who knows)

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon Dec 20, 2023 1:00pm

396 Views

Post# 35794069

RE:RE:bid and ask (manipulation? who knows)

Thanks for your thoughtful input Bene. You are right about the vulnerability posed by the cash situation.

One thing we learned from the fall is that RDW is fully capable of amping up the news releases to create positive energy. We need this now. They also showed that they can do rapid fire updates on clinical trial without waiting 3 months.

I think that there are opportunities for updates on 4 different groups of patients in the coming month while we wait on BTD progress. If RDW follows this forum, these would be great updates.

See my pic share of the ones that may give us great updates. This is my reorganization of the Nov 29 data release for easy of pattern finding.